Skip to content

Advertisement

BMC Infectious Diseases

What do you think about BMC? Take part in

Articles

Sort by
Previous Page Page 3 of 255 Next Page
  1. Content type: Research article

    Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecu...

    Authors: Yu Pang, Damian Zhu, Huiwen Zheng, Jing Shen, Yan Hu, Jie Liu and Yanlin Zhao

    Citation: BMC Infectious Diseases 2017 17:711

    Published on:

  2. Content type: Research

    Dried blood spots (DBS) are a convenient tool to enable diagnostic testing for viral diseases due to transport, handling and logistical advantages over conventional venous blood sampling. A better understandin...

    Authors: Berit Lange, Jennifer Cohn, Teri Roberts, Johannes Camp, Jeanne Chauffour, Nina Gummadi, Azumi Ishizaki, Anupriya Nagarathnam, Edouard Tuaillon, Philippe van de Perre, Christine Pichler, Philippa Easterbrook and Claudia M. Denkinger

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):700

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  3. Content type: Research

    Chronic Hepatitis B Virus (HBV) infection is characterised by the persistence of hepatitis B surface antigen (HBsAg). Expanding HBV diagnosis and treatment programmes into low resource settings will require hi...

    Authors: Ali Amini, Olivia Varsaneux, Helen Kelly, Weiming Tang, Wen Chen, Debrah I. Boeras, Jane Falconer, Joseph D. Tucker, Roger Chou, Azumi Ishizaki, Philippa Easterbrook and Rosanna W. Peeling

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):698

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  4. Content type: Research

    Initial serological testing for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is conducted using either rapid diagnostic tests (RDT) or laboratory-based enzyme immunoassays (EIA)s for d...

    Authors: John V. Parry, Philippa Easterbrook and Anita R. Sands

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):705

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  5. Content type: Research

    There have been few reports on programmatic experience of viral hepatitis testing and treatment in resource-limited settings. To inform the development of the 2017 World Health Organization (WHO) viral hepatit...

    Authors: Azumi Ishizaki, Julie Bouscaillou, Niklas Luhmann, Stephanie Liu, Raissa Chua, Nick Walsh, Sarah Hess, Elena Ivanova, Teri Roberts and Philippa Easterbrook

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):696

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  6. Content type: Research

    The detection and quantification of hepatitis B (HBV) DNA and hepatitis C (HCV) RNA in whole blood collected on dried blood spots (DBS) may facilitate access to diagnosis and treatment of HBV and HCV infection...

    Authors: Berit Lange, Teri Roberts, Jennifer Cohn, Jamie Greenman, Johannes Camp, Azumi Ishizaki, Luke Messac, Edouard Tuaillon, Philippe van de Perre, Christine Pichler, Claudia M. Denkinger and Philippa Easterbrook

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):693

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  7. Content type: Research

    Innovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches to deliver hepatitis testing. ...

    Authors: Joseph D. Tucker, Kathrine Meyers, John Best, Karyn Kaplan, Razia Pendse, Kevin A. Fenton, Isabelle Andrieux-Meyer, Carmen Figueroa, Pedro Goicochea, Charles Gore, Azumi Ishizaki, Giten Khwairakpam, Veronica Miller, Antons Mozalevskis, Michael Ninburg, Ponsiano Ocama…

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):701

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  8. Content type: Research

    Access to hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnostics remains a key bottleneck in scale-up of access to HBV and HCV treatment, particularly in low- and middle-income countries (LMICs) that ...

    Authors: Elena Ivanova Reipold, Alessandra Trianni, Douglas Krakower, Stefano Ongarello, Teri Roberts, Philippa Easterbrook and Claudia Denkinger

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):702

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  9. Content type: Review

    Many people living with chronic HBV infection remain undiagnosed until later stages of disease. Increasing testing and treatment rates form part of the strategy to respond to the WHO goal of eliminating viral ...

    Authors: Shevanthi Nayagam, Elisa Sicuri, Maud Lemoine, Philippa Easterbrook, Lesong Conteh, Timothy B. Hallett and Mark Thursz

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):692

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  10. Content type: Review

    Hepatitis C virus (HCV) infection represents a major public health burden with diverse epidemics worldwide, but at present, only a minority of infected persons have been tested and are aware of their diagnosis...

    Authors: Jake R. Morgan, Maria Servidone, Philippa Easterbrook and Benjamin P. Linas

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):697

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  11. Content type: Research

    Although direct-acting antivirals can achieve sustained virological response rates greater than 90% in Hepatitis C Virus (HCV) infected persons, at present the majority of HCV-infected individuals remain undia...

    Authors: Weiming Tang, Wen Chen, Ali Amini, Debi Boeras, Jane Falconer, Helen Kelly, Rosanna Peeling, Olivia Varsaneux, Joseph D. Tucker and Philippa Easterbrook

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):695

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  12. Content type: Method

    Linking persons with hepatitis B (HBV) and hepatitis C (HCV) infection with appropriate prevention and treatment requires that they first be diagnosed. The World Health Organization (WHO) has developed its fir...

    Authors: Roger Chou, Philippa Easterbrook and Margaret Hellard

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):694

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  13. Content type: Research

    The current low access to virological testing to confirm chronic viraemic HCV infection in low- and middle-income countries (LMIC) is limiting the rollout of hepatitis C (HCV) care. Existing tests are complex,...

    Authors: Elena Ivanova Reipold, Philippa Easterbrook, Alessandra Trianni, Nivedha Panneer, Douglas Krakower, Stefano Ongarello, Teri Roberts, Veronica Miller and Claudia Denkinger

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):707

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  14. Content type: Review

    A large burden of undiagnosed hepatitis virus cases remains globally. Despite the 257 million people living with chronic hepatitis B virus infection, and 71 million with chronic viraemic HCV infection, most pe...

    Authors: Rosanna W. Peeling, Debrah I. Boeras, Francesco Marinucci and Philippa Easterbrook

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):699

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  15. Content type: Review

    Approximately 8% of HIV-infected individuals are co-infected with hepatitis B virus (HBV) in sub-Saharan Africa (SSA). Knowledge of HBV status is important to guide optimal selection of antiretroviral therapy ...

    Authors: Patrick A. Coffie, Matthias Egger, Michael J. Vinikoor, Marcel Zannou, Lameck Diero, Akouda Patassi, Mark H. Kuniholm, Moussa Seydi, Guillaume Bado, Ponsiano Ocama, Monique I. Andersson, Eugène Messou, Albert Minga, Philippa Easterbrook, Kathryn Anastos, François Dabis…

    Citation: BMC Infectious Diseases 2017 17(Suppl 1):706

    Published on:

    This article is part of a Supplement: Volume 17 Supplement 1

  16. Content type: Correction

    An error occurred during the publication of the original article [1].

    Authors: Verónica Elizabeth Mata, Sonia Regina Lambert Passos, Yara Hahr Marques Hökerberg, Guilherme Miguéis Berardinelli, Maria Angelica Borges dos Santos, Levy Vilas Boas Fukuoka, Anna Carolina Fontoura Seixas Rangel Maciel, Cintia Damasceno dos Santos Rodrigues, Aline da Silva Santos and Raquel de Vasconcellos Carvalhaes de Oliveira

    Citation: BMC Infectious Diseases 2017 17:710

    Published on:

    The original article was published in BMC Infectious Diseases 2017 17:594

  17. Content type: Case report

    Haematobacter massiliensis, a rare species of fastidious Gram-negative, non-motile, non-sporing, non-fermentative, pleomorphic, aerobic bacilli, has rarely been documented as the cause...

    Authors: Jing-wei Cheng, Peng Wang, Meng Xiao, Ying Yuan, Timothy Kudinha, Ying Zhao, Fanrong Kong and Ying-chun Xu

    Citation: BMC Infectious Diseases 2017 17:709

    Published on:

  18. Content type: Research article

    There is ongoing controversy regarding abacavir use in the treatment of HIV infection and the risk of subsequent development of cardiovascular disease. It is unclear how the risk varies as exposure accumulates.

    Authors: Kunchok Dorjee, Sanjiv M. Baxi, Arthur L. Reingold and Alan Hubbard

    Citation: BMC Infectious Diseases 2017 17:708

    Published on:

  19. Content type: Research article

    A large number (n = 460) of A(H7N9) human infections have been reported in China from March 2013 through December 2014, and H7N9 outbreaks in humans became an emerging issue for China health, which have caused nu...

    Authors: Wen Dong, Kun Yang, Quanli Xu, Lin Liu and Juan Chen

    Citation: BMC Infectious Diseases 2017 17:704

    Published on:

  20. Content type: Research article

    People working with pigs are at elevated risk of harboring methicillin resistant S. aureus (MRSA) in their nose, which is attributable to occupational exposure to animals harboring livestock adapted S. aureus. To...

    Authors: Jisun Sun, My Yang, Srinand Sreevatsan, Jeffrey B. Bender, Randall S. Singer, Todd P. Knutson, Douglas G. Marthaler and Peter R. Davies

    Citation: BMC Infectious Diseases 2017 17:690

    Published on:

  21. Content type: Research article

    Early HIV diagnosis and initiation onto antiretroviral therapy may prevent ongoing spread of HIV. Risk Tracing Snowball Approach (RTSA) has been shown to be effective in detecting new HIV cases in other settin...

    Authors: Srean Chhim, John Macom, Chettana Pav, Nirada Nim, Phearun Yun, Sopheap Seng, Kolab Chhim, Sovannary Tuot and Siyan Yi

    Citation: BMC Infectious Diseases 2017 17:689

    Published on:

  22. Content type: Research article

    Cytomegalovirus (CMV) is a common cause of congenital infection worldwide and infants with symptomatic congenital CMV (cCMV) infection are at significantly increased risk of developing adverse long-term outcom...

    Authors: Mina Ebrahimi-Rad, Talayeh Seyed Shakeri, Fariba Shirvani, Kiana Shahrokhi and Nader Shahrokhi

    Citation: BMC Infectious Diseases 2017 17:688

    Published on:

  23. Content type: Research article

    This study aimed at estimating the efficiency of palivizumab in the prevention of Respiratory Syncytial Virus (RSV) infection and its sequelae in preterm infants (32day 1-35day 0weeks of gestational age –wGA-) in...

    Authors: M. Sanchez-Luna, R. Burgos-Pol, I. Oyagüez, J. Figueras-Aloy, M. Sánchez-Solís, F. Martinón-Torres and X. Carbonell-Estrany

    Citation: BMC Infectious Diseases 2017 17:687

    Published on:

Previous Page Page 3 of 255 Next Page

Featured videos

View featured videos from across the BMC-series journals

2016 Journal Metrics

Advertisement